9,795
Total Claims
$537K
Drug Cost
904
Beneficiaries
$595
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-58%
Cost per patient vs peers
$595 vs $1,411 avg
-22%
Brand preference vs peers
8.3% vs 10.6% avg
Brand vs Generic
92% generic
Brand: 812 claims · $380K
Generic: 8,945 claims · $155K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 79 | $84K |
| Empagliflozin | 38 | $38K |
| Rivaroxaban | 34 | $33K |
| Fluticasone Propion/Salmeterol | 66 | $33K |
| Semaglutide | 27 | $27K |
| Fluticasone/Vilanterol | 48 | $20K |
| Dulaglutide | 16 | $17K |
| Linagliptin | 17 | $15K |
| Semaglutide | 15 | $14K |
| Levothyroxine Sodium | 630 | $12K |
| Atorvastatin Calcium | 770 | $12K |
| Tiotropium Bromide | 15 | $9,292 |
| Tiotropium Bromide | 15 | $7,330 |
| Dapagliflozin Propanediol | 11 | $7,065 |
| Lisinopril | 606 | $6,283 |
Prescribing Profile
Patient Profile
72
Avg Age
76%
Female
1.04
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data